More than 3,500 leading scientists and clinicians to present advances in CF research and care
ORLANDO, Fla., Oct. 21 /PRNewswire-USNewswire/ -- An international summit will draw more than 3,500 cystic fibrosis experts to Orlando Oct. 23 - 25, 2008 to discuss the latest findings in cystic fibrosis drug research and care.
The annual North American Cystic Fibrosis Conference is the ultimate "meeting of the minds" for leading CF researchers and clinicians. Experts from a range of disciplines come together to exchange ideas and share knowledge, with the goal of accelerating medical breakthroughs. At the 22nd annual conference, key topics will include:
Cystic fibrosis is a life-threatening genetic disease that affects approximately 30,000 children and adults in the United States. Ten million people are unknowing carriers of a CF gene. Fifty years ago, most children with CF died before reaching elementary school. Today, because of Cystic Fibrosis Foundation-supported drug research and care, people with CF are living to a median predicated age of 37.
The 22nd Annual North American Cystic Fibrosis Conference, the largest international gathering of leading cystic fibrosis research scientists and clinicians.
WHEN & WHERE:
Thurs., Oct. 23 - Sat., Oct. 25, 2008 at the Orlando World Center Marriot, Orlando, FL.
PLENARY SESSION HIGHLIGHTS:
INTERVIEWS AVAILABLE WITH:
About the Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation is the leading organization devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation funds CF research, has 80 chapter and branch offices throughout the country, and supports and accredits a nationwide network of 115 CF care centers, which provide vital treatments and other CF resources to patients and families. For more information, visit www.cff.org.
-- Advancements in drug discovery and development; -- The importance of clinical trials; -- Quality improvement and patient outcomes; -- Serving the growing adult CF population; -- Newborn screening for CF and the value of early intervention.
SOURCE Cystic Fibrosis Foundation